ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,305Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 910

$732K Total Retail Price of All Prescriptions

Rank: 61 out of 910

626 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 626 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

11% of this provider’s 626 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,553 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
AMLODIPINE BESYLATE 441 400 1 4
LEVOTHYROXINE SODIUM 417 352 2 1
LISINOPRIL 361 321 3 2
SIMVASTATIN 349 298 4 3
HYDROCODONE-ACETAMINOPHEN 311 222 S3 5 8
OMEPRAZOLE 241 227 6 5
HYDROCHLOROTHIAZIDE 240 213 7 12
METFORMIN HCL 228 185 8 6
LOSARTAN POTASSIUM 227 217 9 15
PRAVASTATIN SODIUM 225 194 10 16
METOPROLOL TARTRATE 223 204 11 7
BENAZEPRIL HCL 187 151 12 89
METOPROLOL SUCCINATE 176 128 13 21
LOVASTATIN 146 140 14 20
FUROSEMIDE 142 119 15 9
ATORVASTATIN CALCIUM 140 128 16 14
FLUTICASONE PROPIONATE 120 106 17 23
SERTRALINE HCL 114 96 18 24
ALENDRONATE SODIUM 111 83 19 22
GABAPENTIN 109 73 20 13
ZOLPIDEM TARTRATE 108 87 21 17
WARFARIN SODIUM 107 92 22 11
POTASSIUM CHLORIDE 99 86 23 18
ADVAIR DISKUS 97 66 24 45
RANITIDINE HCL 95 72 25 28
ATENOLOL 91 83 26 10
DILTIAZEM ER 90 76 27 105
VYTORIN 89 75 28 82
FINASTERIDE 87 87 29 59
TRAZODONE HCL 85 59 30 37
CARVEDILOL 81 72 31 36
TAMSULOSIN HCL 78 73 32 29
PAROXETINE HCL 77 59 33 50
CYMBALTA 73 51 34 58
SPIRIVA 71 44 35 74
CELEBREX 68 55 36 85
FLUOXETINE HCL 66 54 37 49
ALLOPURINOL 66 54 37 33
DOXAZOSIN MESYLATE 61 48 39 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 55 40 44
DIOVAN HCT 54 46 41 133
CRESTOR 53 50 42 26
BENICAR 53 53 42 94
NAMENDA 53 53 42 57
CARISOPRODOL 52 30 R 45 71
TRIAMTERENE-HCTZ 52 47 45 39
MORPHINE SULFATE ER 51 37 S2 47 52
CLOPIDOGREL 51 47 47 35
DONEPEZIL HCL 50 50 49 32
OXYCODONE HCL 50 35 S2 49 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.